Home
>
National Drug Code (NDC)
>
Bleomycin
Bleomycin - 63323-137-20 - (BLEOMYCIN)
Drug Information of Bleomycin
| Product NDC: | 63323-137 |
| Proprietary Name: | Bleomycin |
| Non Proprietary Name: | BLEOMYCIN |
| Active Ingredient(s): | 30 [USP'U]/1 & nbsp; BLEOMYCIN |
| Administration Route(s): | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bleomycin
| Product NDC: | 63323-137 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065185 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090213 |
Package Information of Bleomycin
| Package NDC: | 63323-137-20 |
| Package Description: | 1 VIAL in 1 CARTON (63323-137-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Information of Bleomycin
| NDC Code | 63323-137-20 |
| Proprietary Name | Bleomycin |
| Package Description | 1 VIAL in 1 CARTON (63323-137-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Product NDC | 63323-137 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BLEOMYCIN |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20090213 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | BLEOMYCIN SULFATE |
| Strength Number | 30 |
| Strength Unit | [USP'U]/1 |
| Pharmaceutical Classes | Cytoprotective Agent [EPC] |
